(Q47941073)

6 February 2018

title

Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan (English)

1 reference

6 February 2018

author name string

Takamitsu Inoue

1

1 reference

6 February 2018

Takehiko Segawa

2

1 reference

6 February 2018

Tomomi Kamba

3

1 reference

6 February 2018

Koji Yoshimura

4

1 reference

6 February 2018

Eijiro Nakamura

5

1 reference

6 February 2018

Hiroyuki Nishiyama

6

1 reference

6 February 2018

Noriyuki Ito

7

1 reference

6 February 2018

Toshiyuki Kamoto

8

1 reference

6 February 2018

Tomonori Habuchi

9

1 reference

6 February 2018

Osamu Ogawa

10

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2009

1 reference

6 February 2018

published in

Urology

1 reference

6 February 2018

volume

73

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

1104-1109

1 reference

6 February 2018

Risk of fracture after androgen deprivation for prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Docetaxel plus prednisolone for the treatment of metastatic hormone-refractory prostate cancer: a multicenter Phase II trial in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Three-weekly docetaxel with prednisone is feasible for Japanese patients with hormone-refractory prostate cancer: a retrospective comparative study with weekly docetaxel alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.062

10.1016/J.UROLOGY.2008.07.062

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

release_theubbostfee7nauqpib6aza7q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/theubbostfee7nauqpib6aza7q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

6 February 2018